Today we cover a major Alzheimer's disease genetics study showing common DNA variants matter far more than thought, new data showing ectopic Cushing syndrome should be treated as a time-critical emergency, and blood biomarkers tracking treatment response in spinal muscular atrophy. We also look at the global burden of bone cancer, a novel protein-clearing strategy for neurodegeneration, and how bladder tumors resist immunotherapy, plus a quick rundown of six more notable papers.
Podcast · New episode every day
Researchphilia Daily
A 10‑minute briefing on the newest peer‑reviewed studies, every single day.
The research that's shaping medicine before anyone else is talking about it. Researchphilia Daily delivers a 10-minute briefing on the newest peer-reviewed studies, every single day. Built for clinicians, researchers, and anyone who wants to stay genuinely up to date. Every study we cover is in the Researchphilia app, available on the App Store, with the full abstract and a plain language summary. Save the ones you like and listen to new episodes right inside the app.
Latest episode
Today’s briefing.
Recent
Previous episodes.
A daily briefing on new medical research for busy clinicians. Today we cover a major survival win in small cell lung cancer, a fatal setback in the first human gene editing trial for Duchenne muscular dystrophy, new…
A daily briefing on new medical research for clinicians and the curious. Today we cover a newly identified bacterial toxin behind severe necrotizing enterocolitis, a global burden study on unintentional poisoning, a…
Today's briefing covers a major survival gain in small cell lung cancer, the largest Alzheimer's genetics study to date, and five year results on skipping chemotherapy in HER2 positive breast cancer. We also look at…
Today we cover a New England Journal of Medicine review on adult ADHD, real world data on RSV vaccines and antibodies, why the first solid tumor CAR-T therapy only adds a few months of survival, a new hormonal…
A chemotherapy free regimen beats standard treatment in a major leukemia trial, and a closely watched heart disease drug lowers a key risk marker without lowering heart attacks or strokes. We also cover emerging…
In the app
The same briefing, built in.
Every episode is also available inside Researchphilia, right next to the papers it talks about.
- 1
Open Listen
From the home screen tap “Listen to Research” to start today’s briefing.
- 2
Go hands‑free
Audio keeps playing in the background and on the lock screen. Skip 15 seconds forward or back.
- 3
Save what matters
Heard something interesting? Every study we cover is in the app with the full abstract and a plain‑language summary.
Read it, then listen to it.
Get Researchphilia and turn your commute into rounds.